Title |
Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro
|
---|---|
Published in |
Molecular Cancer Therapeutics, February 2021
|
DOI | 10.1158/1535-7163.mct-20-0244 |
Pubmed ID | |
Authors |
Sarah E Kohrt, Wisam N Awadallah, Robert A Phillips, Thomas C Case, Renjie Jin, Jagpreet S Nanda, Xiuping Yu, Peter E Clark, Yajun Yi, Robert J Matusik, Philip D Anderson, Magdalena M Grabowska |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 36% |
Canada | 1 | 7% |
United Kingdom | 1 | 7% |
Netherlands | 1 | 7% |
Unknown | 6 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 50% |
Scientists | 5 | 36% |
Practitioners (doctors, other healthcare professionals) | 1 | 7% |
Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 24 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 21% |
Researcher | 3 | 13% |
Lecturer | 2 | 8% |
Student > Bachelor | 2 | 8% |
Student > Master | 2 | 8% |
Other | 2 | 8% |
Unknown | 8 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 5 | 21% |
Medicine and Dentistry | 4 | 17% |
Agricultural and Biological Sciences | 2 | 8% |
Nursing and Health Professions | 1 | 4% |
Computer Science | 1 | 4% |
Other | 1 | 4% |
Unknown | 10 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2021.
All research outputs
#4,088,536
of 25,217,627 outputs
Outputs from Molecular Cancer Therapeutics
#781
of 4,071 outputs
Outputs of similar age
#103,190
of 521,100 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#17
of 74 outputs
Altmetric has tracked 25,217,627 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,071 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 521,100 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.